621 related articles for article (PubMed ID: 30293819)
1. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
3. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
Thakur SB; Durando M; Milans S; Cho GY; Gennaro L; Sutton EJ; Giri D; Morris EA
J Magn Reson Imaging; 2018 Feb; 47(2):401-409. PubMed ID: 28640531
[TBL] [Abstract][Full Text] [Related]
4. Association of DW/DCE-MRI features with prognostic factors in breast cancer.
Shao G; Fan L; Zhang J; Dai G; Xie T
Int J Biol Markers; 2017 Mar; 32(1):e118-e125. PubMed ID: 27646773
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Choi BB; Kim SH; Kang BJ; Lee JH; Song BJ; Jeong SH; Yim HW
World J Surg Oncol; 2012 Jun; 10():126. PubMed ID: 22741544
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
7. Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla.
Liu F; Wang M; Li H
World J Surg Oncol; 2018 Dec; 16(1):239. PubMed ID: 30577820
[TBL] [Abstract][Full Text] [Related]
8. Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma.
Cipolla V; Santucci D; Guerrieri D; Drudi FM; Meggiorini ML; de Felice C
Eur J Radiol; 2014 Dec; 83(12):2144-2150. PubMed ID: 25305145
[TBL] [Abstract][Full Text] [Related]
9. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
[TBL] [Abstract][Full Text] [Related]
10. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
Tezcan S; Ozturk FU; Uslu N; Akcay EY
Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
[TBL] [Abstract][Full Text] [Related]
11. Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.
Park SH; Choi HY; Hahn SY
J Magn Reson Imaging; 2015 Jan; 41(1):175-82. PubMed ID: 24353241
[TBL] [Abstract][Full Text] [Related]
12. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
Youk JH; Son EJ; Chung J; Kim JA; Kim EK
Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
15. Is oncotype DX recurrence score (RS) of prognostic value once HER2-positive and. low-ER expression patients are removed?
Milburn M; Rosman M; Mylander C; Tafra L
Breast J; 2013; 19(4):357-64. PubMed ID: 23701403
[TBL] [Abstract][Full Text] [Related]
16. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
17. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
18. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
[TBL] [Abstract][Full Text] [Related]
19. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors.
Park MJ; Cha ES; Kang BJ; Ihn YK; Baik JH
Korean J Radiol; 2007; 8(5):390-6. PubMed ID: 17923781
[TBL] [Abstract][Full Text] [Related]
20. Initial experience of automated breast volume scanning (ABVS) and ultrasound elastography in predicting breast cancer subtypes and staging.
Wang XL; Tao L; Zhou XL; Wei H; Sun JW
Breast; 2016 Dec; 30():130-135. PubMed ID: 27718417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
